Cargando…
Group sequential designs for stepped-wedge cluster randomised trials
BACKGROUND/AIMS: The stepped-wedge cluster randomised trial design has received substantial attention in recent years. Although various extensions to the original design have been proposed, no guidance is available on the design of stepped-wedge cluster randomised trials with interim analyses. In an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632563/ https://www.ncbi.nlm.nih.gov/pubmed/28653550 http://dx.doi.org/10.1177/1740774517716937 |
_version_ | 1783269727559221248 |
---|---|
author | Grayling, Michael J Wason, James MS Mander, Adrian P |
author_facet | Grayling, Michael J Wason, James MS Mander, Adrian P |
author_sort | Grayling, Michael J |
collection | PubMed |
description | BACKGROUND/AIMS: The stepped-wedge cluster randomised trial design has received substantial attention in recent years. Although various extensions to the original design have been proposed, no guidance is available on the design of stepped-wedge cluster randomised trials with interim analyses. In an individually randomised trial setting, group sequential methods can provide notable efficiency gains and ethical benefits. We address this by discussing how established group sequential methodology can be adapted for stepped-wedge designs. METHODS: Utilising the error spending approach to group sequential trial design, we detail the assumptions required for the determination of stepped-wedge cluster randomised trials with interim analyses. We consider early stopping for efficacy, futility, or efficacy and futility. We describe first how this can be done for any specified linear mixed model for data analysis. We then focus on one particular commonly utilised model and, using a recently completed stepped-wedge cluster randomised trial, compare the performance of several designs with interim analyses to the classical stepped-wedge design. Finally, the performance of a quantile substitution procedure for dealing with the case of unknown variance is explored. RESULTS: We demonstrate that the incorporation of early stopping in stepped-wedge cluster randomised trial designs could reduce the expected sample size under the null and alternative hypotheses by up to 31% and 22%, respectively, with no cost to the trial’s type-I and type-II error rates. The use of restricted error maximum likelihood estimation was found to be more important than quantile substitution for controlling the type-I error rate. CONCLUSION: The addition of interim analyses into stepped-wedge cluster randomised trials could help guard against time-consuming trials conducted on poor performing treatments and also help expedite the implementation of efficacious treatments. In future, trialists should consider incorporating early stopping of some kind into stepped-wedge cluster randomised trials according to the needs of the particular trial. |
format | Online Article Text |
id | pubmed-5632563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-56325632017-10-08 Group sequential designs for stepped-wedge cluster randomised trials Grayling, Michael J Wason, James MS Mander, Adrian P Clin Trials Articles BACKGROUND/AIMS: The stepped-wedge cluster randomised trial design has received substantial attention in recent years. Although various extensions to the original design have been proposed, no guidance is available on the design of stepped-wedge cluster randomised trials with interim analyses. In an individually randomised trial setting, group sequential methods can provide notable efficiency gains and ethical benefits. We address this by discussing how established group sequential methodology can be adapted for stepped-wedge designs. METHODS: Utilising the error spending approach to group sequential trial design, we detail the assumptions required for the determination of stepped-wedge cluster randomised trials with interim analyses. We consider early stopping for efficacy, futility, or efficacy and futility. We describe first how this can be done for any specified linear mixed model for data analysis. We then focus on one particular commonly utilised model and, using a recently completed stepped-wedge cluster randomised trial, compare the performance of several designs with interim analyses to the classical stepped-wedge design. Finally, the performance of a quantile substitution procedure for dealing with the case of unknown variance is explored. RESULTS: We demonstrate that the incorporation of early stopping in stepped-wedge cluster randomised trial designs could reduce the expected sample size under the null and alternative hypotheses by up to 31% and 22%, respectively, with no cost to the trial’s type-I and type-II error rates. The use of restricted error maximum likelihood estimation was found to be more important than quantile substitution for controlling the type-I error rate. CONCLUSION: The addition of interim analyses into stepped-wedge cluster randomised trials could help guard against time-consuming trials conducted on poor performing treatments and also help expedite the implementation of efficacious treatments. In future, trialists should consider incorporating early stopping of some kind into stepped-wedge cluster randomised trials according to the needs of the particular trial. SAGE Publications 2017-06-27 2017-10 /pmc/articles/PMC5632563/ /pubmed/28653550 http://dx.doi.org/10.1177/1740774517716937 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles Grayling, Michael J Wason, James MS Mander, Adrian P Group sequential designs for stepped-wedge cluster randomised trials |
title | Group sequential designs for stepped-wedge cluster randomised trials |
title_full | Group sequential designs for stepped-wedge cluster randomised trials |
title_fullStr | Group sequential designs for stepped-wedge cluster randomised trials |
title_full_unstemmed | Group sequential designs for stepped-wedge cluster randomised trials |
title_short | Group sequential designs for stepped-wedge cluster randomised trials |
title_sort | group sequential designs for stepped-wedge cluster randomised trials |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632563/ https://www.ncbi.nlm.nih.gov/pubmed/28653550 http://dx.doi.org/10.1177/1740774517716937 |
work_keys_str_mv | AT graylingmichaelj groupsequentialdesignsforsteppedwedgeclusterrandomisedtrials AT wasonjamesms groupsequentialdesignsforsteppedwedgeclusterrandomisedtrials AT manderadrianp groupsequentialdesignsforsteppedwedgeclusterrandomisedtrials |